-
公开(公告)号:US07741327B2
公开(公告)日:2010-06-22
申请号:US12400065
申请日:2009-03-09
申请人: Steven Joseph Berthel , John A Brinkman , Stuart Hayden , Nancy-Ellen Haynes , Robert Francis Kester , Lee Apostle McDermott , Yimin Qian , Ramakanth Sarabu , Nathan Robert Scott , Jefferson Wright Tilley
发明人: Steven Joseph Berthel , John A Brinkman , Stuart Hayden , Nancy-Ellen Haynes , Robert Francis Kester , Lee Apostle McDermott , Yimin Qian , Ramakanth Sarabu , Nathan Robert Scott , Jefferson Wright Tilley
IPC分类号: A61K31/497 , A61K31/4439 , A61K31/433 , A61K31/428 , A61K31/426 , A61K31/423 , A61K31/421 , A61K31/4155 , C07D403/12 , C07D401/12 , C07D285/08 , C07D277/82 , C07D277/38 , C07D263/54 , C07D263/48 , C07D231/56 , C07D231/38
CPC分类号: C07D403/12 , C07D401/12 , C07D405/14 , C07D413/14 , C07D417/12
摘要: Provided herein are compounds of the formula (I): as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of metabolic diseases and disorders such as, for example, type II diabetes mellitus.
摘要翻译: 本文提供式(I)的化合物及其药学上可接受的盐,其中取代基如说明书中公开的那些。 这些化合物和含有它们的药物组合物可用于治疗代谢疾病和病症,例如II型糖尿病。